DVOŘÁK, Petr, Aleš HAMPL and Dana DVOŘÁKOVÁ. Fibroblast growth factor signaling in embryonic and cancer stem cells. FEBS Letters. 2006, vol. 580, No 12, p. 2869-2874. ISSN 0014-5793.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Fibroblast growth factor signaling in embryonic and cancer stem cells
Name in Czech Signalizace fibroblastového růstového faktoru v embryonálních a nádorových kmenových buňkách
Authors DVOŘÁK, Petr (203 Czech Republic, guarantor), Aleš HAMPL (203 Czech Republic) and Dana DVOŘÁKOVÁ (203 Czech Republic).
Edition FEBS Letters, 2006, 0014-5793.
Other information
Original language English
Type of outcome Article in a journal
Field of Study Genetics and molecular biology
Country of publisher Netherlands
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 3.372
RIV identification code RIV/00216224:14110/06:00017761
Organization unit Faculty of Medicine
UT WoS 000238914000035
Keywords in English stem cells
Tags stem cells
Tags International impact
Changed by Changed by: prof. Ing. Petr Dvořák, CSc., učo 47260. Changed: 25/6/2008 10:45.
Abstract
Cancer stem cells are cancer cells that originate from the transformation of normal stem cells. The most important property of any stem cell is the ability to self-renew. Through this property, there are striking parallels between normal stem cells and cancer stem cells. Both cell types share various markers of "stemness". In particular, normal stem cells and cancer stem cells utilize similar molecular mechanisms to drive self-renewal, and similar signaling pathways may induce their differentiation. The fibroblast growth factor 2 (FGF-2) pathway is one of the most significant regulators of human embryonic stem cell (hESC) self-renewal and cancer cell tumorigenesis. Here we summarize recent data on the effects of FGF-2 and its receptors on hESCs and leukemic stem/progenitor cells. Also, we discuss the similarities of these findings with stem cell renewal and differentiation phenotypes.
Abstract (in Czech)
Článek shrnuje recentní informace o účinku fibroblastového růstového faktoru (FGF2) a jeho receptorů na lidské embryonální buňky a na progenitorové buňky leukémie.
Links
AV0Z50390512, plan (intention)Name: Molekulární, buněčné a systémové mechanizmy závažných onemocnění lidského organizmu, jejich diagnostika, terapie a farmakoterapie
GA301/03/1122, research and development projectName: FGF-2 a FGFR-3 v chronické myeloidní leukémii. Studie na modelových leukemických buněčných liniích a na CD34+ progenitorových buňkách pacientů
LC06077, research and development projectName: Centrum chemické genetiky
Investor: Ministry of Education, Youth and Sports of the CR
1M0538, research and development projectName: Centrum buněčné terapie a tkáňových náhrad
PrintDisplayed: 11/5/2024 03:08